Comparison Overview
Grifols
Grifols
Parc Empresarial Can Sant Joan, Sant Cugat del Vallès, 08174, ES
Last Update: 04/04/2026
Grifols is a global healthcare company founded in Barcelona in 1909 committed to improving the health and well-being of people all over the world. A leader in essential plasma-derived medicines and transfusion medicine, we develop, produce and provide innovative healt...
Johnson & Johnson Innovative Medicine
N/A
Last Update: 31/03/2026
At Johnson & Johnson Innovative Medicine, we innovate with purpose, to lead where medicine is going. The experiences of patients around the world inform and inspire our science-based innovations, which continue to change and save lives. Applying rigorous science with co...
Compliance Ranges Comparison
Grifols
Johnson & Johnson Innovative Medicine
Benchmark & Cyber Underwriting Signals
Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)
No incidents recorded for Grifols in 2026.
Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)
No incidents recorded for Johnson & Johnson Innovative Medicine in 2026.
Incident History - Grifols (X = Date, Y = Severity)
Grifols cyber incidents detection timeline including parent company and subsidiaries.
Incident History - Johnson & Johnson Innovative Medicine (X = Date, Y = Severity)
Johnson & Johnson Innovative Medicine cyber incidents detection timeline including parent company and subsidiaries.
Notable Incidents
Grifols
Johnson & Johnson Innovative Medicine
FAQ
Latest Global CVEs
Pronetiqs IntraVUE versions 3.2.1a14 and prior have an inadequate encryption strength vulnerability which could allow an attacker to steal admin credentials via weak hash or a pass-the-hash attack.
Pronetiqs IntraVUE versions 3.2.1a14 and prior have an exposure of sensitive system information to an unauthorized control sphere vulnerability which could allow for asset discovery by unauthenticated users.
Pronetiqs IntraVUE versions 3.2.1a14 and prior have an unintended proxy or intermediary vulnerability which could allow an attacker to use an active proxy, which would bypass OT segmentation.
Pronetiqs IntraVUE Versions 3.2.1a14 and prior have a plaintext storage of a password vulnerability that could expose cleartext credentials through the API.
Pronetiqs IntraVUE versions 3.2.1a14 and prior have an exposure of sensitive system information to an unauthorized control sphere vulnerability which could expose the underlying host/share filesystem.